300 related articles for article (PubMed ID: 33277832)
1. Effect of colorectal resection combined with intraoperative radiofrequency ablation in treating colorectal cancer with liver metastasis and analysis of its prognosis.
Fu T; He L; Liu F
J BUON; 2020; 25(5):2171-2179. PubMed ID: 33277832
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
[No Abstract] [Full Text] [Related]
4. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
[TBL] [Abstract][Full Text] [Related]
5. Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation.
Vietti Violi N; Duran R; Demartines N; Sempoux C; Guiu B; Bize PE; Sala N; Halkic N; Knebel JF; Denys A
Int J Hyperthermia; 2018 Nov; 34(7):1020-1028. PubMed ID: 29506424
[TBL] [Abstract][Full Text] [Related]
6. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer.
Lee BC; Lee HG; Park IJ; Kim SY; Kim KH; Lee JH; Kim CW; Lee JL; Yoon YS; Lim SB; Yu CS; Kim JC
Medicine (Baltimore); 2016 Sep; 95(39):e4999. PubMed ID: 27684857
[TBL] [Abstract][Full Text] [Related]
7. Solitary colorectal liver metastasis: resection determines outcome.
Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
[TBL] [Abstract][Full Text] [Related]
8. Resectable recurrent colorectal liver metastasis: can radiofrequency ablation replace repeated metastasectomy?
Mao R; Zhao JJ; Bi XY; Zhang YF; Han Y; Li ZY; Zhao H; Cai JQ
ANZ J Surg; 2019 Jul; 89(7-8):908-913. PubMed ID: 31090189
[TBL] [Abstract][Full Text] [Related]
9. Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases.
Tago T; Katsumata K; Udou R; Kasahara K; Mazaki J; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Sugimoto K; Itoi T; Tsuchida A
Anticancer Res; 2021 Nov; 41(11):5539-5547. PubMed ID: 34732424
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
Zeman M; Maciejewski A; Półtorak S; Kryj M
Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
[TBL] [Abstract][Full Text] [Related]
11. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
12. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis.
White RR; Avital I; Sofocleous CT; Brown KT; Brody LA; Covey A; Getrajdman GI; Jarnagin WR; Dematteo RP; Fong Y; Blumgart LH; D'Angelica M
J Gastrointest Surg; 2007 Mar; 11(3):256-63. PubMed ID: 17458595
[TBL] [Abstract][Full Text] [Related]
13. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P
Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
15. The neutrophil-to-lymphocyte ratio as a predictor for recurrence of colorectal liver metastases following radiofrequency ablation.
Chang Z; Zheng J; Ma Y; Zhao J; Wang C; Liu Z
Med Oncol; 2014 Mar; 31(3):855. PubMed ID: 24477649
[TBL] [Abstract][Full Text] [Related]
16. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases.
Ko S; Jo H; Yun S; Park E; Kim S; Seo HI
World J Gastroenterol; 2014 Jan; 20(2):525-31. PubMed ID: 24574721
[TBL] [Abstract][Full Text] [Related]
18. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Sawayama H; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Kawanaka K; Yamashita Y; Baba H
Int J Clin Oncol; 2019 Mar; 24(3):288-295. PubMed ID: 30328530
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
[TBL] [Abstract][Full Text] [Related]
20. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
